This is mainly due to the incremented levels of pro-inflammatory agents (Neuropeptide Y (NPY), CGRP) that are associated with abdominal obesity and blamed to be in association with the pain manifestation in those individuals with migraine (43). This evidence concerns the gene NPY and migraine disorder.